Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LSS | P48449 | 17/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MOGAT2 | Q3SYC2 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6401256 | 0.95 | LSS (0.45) | LSSMEN1KMT2AMOGAT2 | |
| SCHEMBL6403822 | 0.94 | LSS (0.47) | LSSMEN1KMT2AMOGAT2 | |
| SCHEMBL6400492 | 0.94 | LSS (0.47) | LSSMEN1KMT2AMOGAT2 | |
| SCHEMBL6405900 | 0.94 | LSS (0.46) | LSSMEN1KMT2A | |
| SCHEMBL6403997 | 0.89 | LSS (0.46) | LSSMEN1KMT2A | |
| SCHEMBL6397866 | 0.89 | LSS (0.46) | LSSMEN1KMT2A | |
| SCHEMBL6397330 | 0.87 | LSS (0.44) | LSSMEN1KMT2A | |
| SCHEMBL6399404 | 0.86 | LSS (0.43) | LSSMEN1KMT2A | |
| SCHEMBL6400517 | 0.86 | MGAT2 (0.40) | LSSMOGAT2 | |
| SCHEMBL5637397 | 0.85 | LSS (0.48) | LSSMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050020624-A1 | Dihydroindole and tetrahydroquinoline derivatives | AEBI JOHANNES (CH) | 2005-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020624-A1 | Dihydroindole and tetrahydroquinoline derivatives | CYP46A1, LSS, CYP51A1 | LSS 2/4885MEN1 402/4885KMT2A 2451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.